Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population
Authors:
- Ross J. SimpsonRSRoss J. Simpson
- James SignorovitchJSJames Signorovitch
- Howard BirnbaumHBHoward Birnbaum
- Jasmina IvanovaJIJasmina Ivanova
- Cristina ConnollyCCCristina Connolly
- Yohanne KidoleziYKYohanne Kidolezi
- Andreas KuznikAKAndreas Kuznik
- 1 December 2009
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 84 (12) , 1065-1072
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 36 references indexed in Scilit:
- The Effect of Medicare Part D on Drug and Medical SpendingNew England Journal of Medicine, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: A large database analysis of managed care plans in the United StatesClinical Therapeutics, 2008
- Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: A substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified TitrationAmerican Heart Journal, 2007
- Molecular Basis of Differences Among Statins and a Comparison with Antioxidant VitaminsThe American Journal of Cardiology, 2006
- Persistence and adherence to cholesterol lowering agents: Evidence from Régie de l'Assurance Maladie du Québec dataAmerican Heart Journal, 2006
- Heart Disease and Stroke Statistics—2006 UpdateCirculation, 2006
- Impact of Appropriate Pharmaceutical Therapy for Chronic Conditions on Direct Medical Costs and Workplace Productivity: A Review of the LiteratureDisease Management, 2004
- Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemiaAtherosclerosis, 2002
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998